The pharmaceutical industry is aggressively evolving, with increasing demand for high-efficacy Active Pharmaceutical Ingredients (APIs). Dulaglutide, a GLP-1 receptor agonist, stands as example of this trend. To meet this demand, US-based manufacturing services are emerging. These providers offer a detailed suite of capabilities, from research and